Table 1 and Supplemental Table 1 describe three RCTs, where Norgaard et al. (2021) pooled findings from three individual RCTs of Glucagon-like peptide-1 receptor agonists which all had dementia as an outcome. The gene discussed is GLP1R; the disease is dementia.